Robust sterility testing is essential to ensure the safety of cell therapies. However, traditional culture-based analysis takes several weeks to confirm a therapeutic’s microbial contamination, which prevents clinicians from obtaining these results before treatment. Scientists require new methods that offer high sensitivity, broad detection capabilities, and faster results.
Download this application note to learn how the microbial detection capabilities of real-time PCR-based bacterial and fungal kits compare to those of culture-based sterility testing.
